🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s KNSA Holdings & Trades

First Buy
Q3 2020
Duration Held
13 Quarters
Largest Add
Q4 2021
+303,300 Shares
Current Position
165,477 Shares
$12.35 M Value

Renaissance Technologies (RenTech)'s KNSA Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 165,477 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $12.35 M, representing 0.02% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 13 quarters.

Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in KNSA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 303,300 shares. Largest reduction occurred in Q1 2022, reducing 144,600 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +97,400 Add 143.07% 165,477 $74.61
Q2 2026 +68,077 New Buy 68,077 $63.95
Q3 2023 -84,447 Sold Out 0 $0.00
Q2 2023 -53,733 Reduce 38.89% 84,447 $0.01
Q1 2023 +71,480 Add 107.17% 138,180 $0.01
Q4 2022 -55,100 Reduce 45.24% 66,700 $0.01
Q3 2022 +67,800 Add 125.56% 121,800 $12.84
Q2 2022 -104,700 Reduce 65.97% 54,000 $9.69
Q1 2022 -144,600 Reduce 47.68% 158,700 $9.94
Q4 2021 +303,300 New Buy 303,300 $11.77
Q1 2021 -16,700 Sold Out 0 $0.00
Q4 2020 +1,000 Add 6.37% 16,700 $17.66
Q3 2020 +15,700 New Buy 15,700 $15.35

Renaissance Technologies (RenTech)'s Kiniksa Pharmaceuticals International plc Investment FAQs

Renaissance Technologies (RenTech) first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q3 2020, acquiring 15,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Kiniksa Pharmaceuticals International, plc (KNSA) for 13 quarters since Q3 2020.

Renaissance Technologies (RenTech)'s largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q4 2021, adding 303,300 shares worth $3.57 M.

According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 165,477 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $12.35 M.

As of the Q3 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.02% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 303,300 shares, as reported at the end of Q4 2021.